HomeARX • ASX
Follow
Aroa Biosurgery Ltd
Previous close
$0.56
Day range
$0.56 - $0.57
Year range
$0.49 - $1.10
Market cap
192.39M AUD
Avg Volume
365.21K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
.INX
0.089%
Financials
Income Statement
Revenue
Net income
(NZD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 15.94M | 8.64% |
Operating expense | 16.25M | 25.92% |
Net income | -3.15M | -497.35% |
Net profit margin | -19.79 | -465.80% |
Earnings per share | — | — |
EBITDA | -2.02M | -1,615.04% |
Effective tax rate | -2.29% | — |
Balance Sheet
Total assets
Total liabilities
(NZD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 34.95M | -30.26% |
Total assets | 112.57M | -3.02% |
Total liabilities | 15.43M | 9.52% |
Total equity | 97.14M | — |
Shares outstanding | 343.44M | — |
Price to book | 2.02 | — |
Return on assets | -6.33% | — |
Return on capital | -6.85% | — |
Cash Flow
Net change in cash
(NZD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -3.15M | -497.35% |
Cash from operations | -3.65M | -59.20% |
Cash from investing | 968.50K | -79.64% |
Cash from financing | -278.00K | -85.33% |
Net change in cash | -2.79M | -195.95% |
Free cash flow | -1.94M | -454.39% |
About
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, USA and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward.
The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
CEO
Founded
2008
Website
Employees
261